Cargando…
Prediction of potential drug interactions between repurposed COVID-19 and antitubercular drugs: an integrational approach of drug information software and computational techniques data
INTRODUCTION: Tuberculosis is a major respiratory disease globally with a higher prevalence in Asian and African countries than rest of the world. With a larger population of tuberculosis patients anticipated to be co-infected with COVID-19 infection, an ongoing pandemic, identifying, preventing and...
Autores principales: | Thomas, Levin, Birangal, Sumit Raosaheb, Ray, Rajdeep, Sekhar Miraj, Sonal, Munisamy, Murali, Varma, Muralidhar, S.V., Chidananda Sanju, Banerjee, Mithu, Shenoy, Gautham G., Rao, Mahadev |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8404633/ https://www.ncbi.nlm.nih.gov/pubmed/34471515 http://dx.doi.org/10.1177/20420986211041277 |
Ejemplares similares
-
Influence of Single Nucleotide Polymorphisms on Rifampin Pharmacokinetics in Tuberculosis Patients
por: Thomas, Levin, et al.
Publicado: (2020) -
Lineage classification and antitubercular drug resistance surveillance of Mycobacterium tuberculosis by whole-genome sequencing in Southern India
por: Rao, Mahadev, et al.
Publicado: (2023) -
Influence of N-acetyltransferase 2 (NAT2) genotype/single nucleotide polymorphisms on clearance of isoniazid in tuberculosis patients: a systematic review of population pharmacokinetic models
por: Thomas, Levin, et al.
Publicado: (2022) -
Potential Drug Interactions of Repurposed COVID-19 Drugs with Lung Cancer Pharmacotherapies
por: Baburaj, Gayathri, et al.
Publicado: (2021) -
Antitubercular drugs: Drug-induced hepatotoxicity: case report
Publicado: (2022)